Loading…
Please register to continue your trial period!
meRfi Microbiome provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.
Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.
Start your free trial and transform your understanding of the gut microbiota today!
Farnesoid X receptor (FXR / NR1H4) agonists prevent chemically induced intestinal inflammation, improve colitis symptoms, inhibit epithelial permeability, and reduce the loss of goblet cells. Additionally, fewer pro-inflammatory cytokines are produced in vivo in the mouse colon mucosa and ex vivo in various immune cell populations. FXR agonists should be explored as a novel therapeutic strategy for [Inflammatory Bowel Disease](brain://UUceGF1S-UOZoI1…